Jesper Heldrup (Former)
1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Glucarpidase efficacy in mitigating methotrexate toxicity is unaffected by concurrent administration of folinic acid
- Contribution to journal › Article
- 2025
-
Mark
Retraction Note : New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid (Cancer Chemotherapy and Pharmacology, (2025), 95, 1, (41), 10.1007/s00280-025-04749-w)
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
Simultaneous determination of folate and methotrexate metabolites in serum by LC-MS/MS during high-dose methotrexate therapy
(2021) In Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1186.
- Contribution to journal › Article
- 2019
-
Mark
Plasma creatinine as predictor of delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia : A Danish population-based study
- Contribution to journal › Article
- 2016
-
Mark
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the nordic countries.
- Contribution to journal › Article
-
Mark
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia
- Contribution to journal › Article
-
Mark
Trisomy 8 in pediatric acute myeloid leukemia : A NOPHO-AML study
- Contribution to journal › Article
- 2015
-
Mark
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
- Contribution to journal › Article
-
Mark
The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
- Contribution to journal › Article
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
- Contribution to journal › Article
